CN111407805A - Traditional Chinese medicine formula for treating bone diseases - Google Patents

Traditional Chinese medicine formula for treating bone diseases Download PDF

Info

Publication number
CN111407805A
CN111407805A CN202010316280.2A CN202010316280A CN111407805A CN 111407805 A CN111407805 A CN 111407805A CN 202010316280 A CN202010316280 A CN 202010316280A CN 111407805 A CN111407805 A CN 111407805A
Authority
CN
China
Prior art keywords
traditional chinese
chinese medicine
medicine formula
pain
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010316280.2A
Other languages
Chinese (zh)
Inventor
李春雨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010316280.2A priority Critical patent/CN111407805A/en
Publication of CN111407805A publication Critical patent/CN111407805A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/237—Notopterygium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/238—Saposhnikovia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/268—Asarum (wild ginger)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282—Artemisia, e.g. wormwood or sagebrush
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/483—Gleditsia (locust)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine formula for treating osteopathy, which is characterized by comprising the following raw material medicines in parts by weight:

Description

Traditional Chinese medicine formula for treating bone diseases
Technical Field
The invention relates to the technical field, in particular to a traditional Chinese medicine formula for treating bone diseases.
Background
The orthopedic diseases are stubborn diseases seriously harming human health, and mainly comprise hyperosteogeny, rheumatism, arthritis, cervical spondylosis, lumbar intervertebral disc protrusion, scapulohumeral periarthritis, sciatica and the like in modern medicine. Such as common lumbar disc herniation and rheumatism. Lumbar intervertebral disc protrusion is a common disease, frequently encountered disease and tends to increase year by year. The rheumatism bone disease has high clinical morbidity, complex etiology, large treatment difficulty and high recurrence rate, and is a common chronic disease and stubborn disease. Both diseases belong to the category of arthralgia syndrome in traditional Chinese medicine. The traditional Chinese medicine considers that the invasion of wind-cold-dampness pathogen and acute and chronic injury cause the obstruction of channels and collaterals and unsmooth circulation of qi and blood, so that the former people have the saying of ' obstruction and blockage ', obstruction of pain and no pain in dredging '. The onset of lumbar disc herniation is caused by rupture of the annulus fibrosus of the lumbar disc, herniation of the nucleus pulposus, and compression of the dural sac and nerve roots. The treatment of the lumbar intervertebral disc protrusion is realized by the methods of acupuncture, cupping, massage and the like in traditional Chinese medicine. The above method can effectively relieve mechanical stress, but it cannot effectively eliminate chemical irritation, and has a long treatment course.
Disclosure of Invention
In view of the above, the present invention provides a method for producing
In order to achieve the purpose, the invention provides the following technical scheme:
the traditional Chinese medicine formula for treating bone diseases is characterized by comprising the following raw material medicines in parts by weight:
Figure BDA0002459707960000011
Figure BDA0002459707960000021
preferably, in the formula of the traditional Chinese medicine for treating bone diseases, the raw materials of the formula comprise, by weight:
Figure BDA0002459707960000022
preferably, in the formula of the traditional Chinese medicine for treating bone diseases, the raw materials of the formula comprise, by weight:
Figure BDA0002459707960000023
Figure BDA0002459707960000031
the compatibility effect is as follows:
notopterygium root, rhizoma Et radix Notopterygii, being pungent, bitter and warm in nature, has the effects of dispelling exterior cold, expelling wind-damp, benefiting joints, and relieving pain.
Chuan Xiong is pungent and warm in nature and flavor, and has the effects of promoting blood circulation, promoting qi circulation, dispelling wind and relieving pain.
Safflower, pungent in flavor; the nature and the temperature; heart and liver meridian entered; has effects in promoting blood circulation, dispelling blood stasis, and dredging channels; can be used for treating amenorrhea due to blood stagnation, puerperal stagnation, abdominal mass, traumatic injury, pain, measles without adequate eruption.
Myrrh, bitter in taste; the nature is flat; heart, liver and spleen meridians entered; has effects in promoting blood circulation, relieving pain, eliminating swelling, and promoting granulation; can be used for treating amenorrhea, abdominal pain, gastralgia, traumatic injury, carbuncle, swelling, and pyocutaneous disease.
Radix Saposhnikoviae, pungent, sweet and slightly warm in nature and flavor, has effects of dispelling pathogenic wind, relieving exterior syndrome, eliminating dampness, and relieving pain.
The liquorice has sweet and mild nature and flavor, and has the functions of tonifying spleen and qi, clearing away heat and toxic materials, eliminating phlegm and stopping cough, relieving spasm and pain and regulating.
Asarum herb, pungent in flavor; the nature and the temperature; entering heart, lung and kidney meridians; has effects in relieving exterior syndrome, dispelling cold, expelling pathogenic wind, relieving pain, inducing resuscitation, warming lung, and eliminating phlegm; can be used for treating wind-cold type common cold, headache, toothache, rheumatalgia, and cough due to lung cold.
Frankincense, pungent and bitter in flavor; the nature and the temperature; heart, liver and spleen meridians entered; has effects in promoting blood circulation, relieving pain, eliminating swelling, and promoting granulation; can be used for treating dysmenorrhea, amenorrhea, gastralgia, rheumatic arthralgia, traumatic injury, carbuncle, swelling, and pyocutaneous disease.
The traditional Chinese medicine of radix ranunculi ternati (RadixRanunculus ternatus) is the dry root tuber of Ranunculus ternatus (Ranunculus ternatus Thunb) of Ranunculaceae, which is also called as: san scattered grass (Zhejiang), radix ranunculi ternati (Henan), radix pini sylvestris (Anhui), and flos chrysanthemi (Guangxi) are newly found herbal medicines in Xinyang areas in Henan in the 50 th century in 20 th century, and all provinces of China are distributed, and the text records are firstly found in a Chinese herbal medicine manual, and are collected and carried in the pharmacopoeia of the people's republic of China from the 1977 edition. Radix ranunculi ternati is warm in nature, sweet and pungent in flavor, enters liver and lung channels, and has the effects of clearing heat and removing toxicity, relieving swelling and resolving masses, relieving cough and eliminating phlegm and the like.
Spina Gleditsiae (dry spina Gleditsiae) with traditional Chinese medicine name of Gleditsia sinensis Lam (Gleditsia sinensis Lam.) Chinensis L am. of Leguminosae, and has effects of relieving swelling, removing toxic substance, expelling pus, and killing parasite.
Pubescent angelica root, pungent and bitter in flavor; mild sexual temperature; entering kidney and bladder meridians; has effects in expelling pathogenic wind, removing dampness, relieving pain and pain; can be used for treating arthralgia due to wind-cold-dampness, lumbago, gonalgia, shaoyin headache due to wind-cold-dampness, and headache.
The folium artemisiae argyi can dispel cold to relieve pain, warm meridians and stop bleeding; can be used for treating lower abdomen psychroalgia, hematemesis, epistaxis, metrorrhagia, metrostaxis, and pregnancy hemorrhage.
So that the medicinal materials can play the drug effect together according to the principle of monarch, minister, assistant and guide.
According to the technical scheme, compared with the prior art, the traditional Chinese medicine formula for treating the bone disease is scientifically combined, multiple traditional Chinese medicinal materials are carefully screened out and scientifically combined, and the traditional Chinese medicine composition can effectively treat the bone disease. And has the advantages of low cost, quick response, short treatment course, high cure rate and lasting effect.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1:
selecting:
Figure BDA0002459707960000041
Figure BDA0002459707960000051
the action principle is as follows: the traditional Chinese medicinal materials are soaked for 2-3 hours in advance, then the traditional Chinese medicinal materials are put into a pot to be distilled for 10-15 minutes, the dosage time is not too long when the traditional Chinese medicinal materials are heated and hot-compressed at the later stage, so that large-particle salt without iodine is added during the material preparation and the materials are fried by small fire, when the cracked sound can be heard, a gunny bag containing salt is arranged, the materials are fished out for standby when the hands are scalded by hands, the hot-compressing is carried out once a day, the hot-compressing time is not less than one hour, one treatment course is one month, and.
The beneficial effects of using the liniment of the present invention are further illustrated by clinical trial data and specific examples below:
the diseases applicable to the traditional Chinese medicine liniment have clinical manifestation symptoms: fracture, bone fissure, arthritis, rheumatism, lumbago, leg pain, muscular atrophy, synovitis, scapulohumeral periarthritis, numbness of limbs, lumbar disc herniation, muscle and joint pain, ischialgia, hyperostosis, soft tissue contusion, muscle strain, gout, etc.
Trial objects: age 29-72 years, 1000 people.
The using method comprises the following steps: the skin of the patient is cleaned and dried. The traditional Chinese medicine formula prepared in the example 1 is directly applied to an affected part, hot compress is carried out for more than one hour every day, the curative effect is shown in three treatment courses, and whether relapse occurs or not is shown after half a year.
And (4) judging the standard: (1) the effect is shown: the pain disappears, and no recurrence occurs within half a year; (2) the method has the following advantages: compared with the prior art, the product is improved to a certain extent; (3) and (4) invalidation: no change in symptoms.
The trial results are as follows:
Figure BDA0002459707960000052
Figure BDA0002459707960000061
typical cases are:
if Li Yi and women are 50 years old, the patients with rheumatic arthritis and knee joint pain are in 3 years old, and the taking of various medicines is not good. After the traditional Chinese medicine formula is used for 1 course of treatment, knee pain is obviously relieved, and joint pain is relieved; after 3 months, the leg movements returned to normal after the symptoms had disappeared.
Liu is a Chinese medicine and a western medicine, male and female are 60 years old, suffer from rheumatic arthritis for 5 years, and are uncomfortable on the whole body every rainy day, and in severe cases, the legs can not walk, and the effect of taking the Chinese medicine and the western medicine is not obvious. After the traditional Chinese medicine formula is used for 2 treatment courses, the pain is obviously improved, and after the traditional Chinese medicine formula is continuously used for 3 treatment courses, the pain of the shoulder and the knee joint is avoided in rainy days.
For example, a male with age of 45 years suffers from hyperosteogeny and lumbar pain for 8 years, and when the lumbar pain is severe, the whole body is painful and can not work, and the taking of Chinese and western medicines and the massage are not good. After the traditional Chinese medicine formula is used for 1 course of treatment, pain is relieved, symptoms are obviously improved after 3 courses of treatment, the pain basically disappears after 6 courses of treatment, the curative effect is consolidated after the traditional Chinese medicine formula is continuously used for 3 months, and the symptoms disappear.
The embodiments are described in a progressive manner in the specification, each embodiment focuses on differences from other embodiments, and the same and similar parts among the embodiments are referred to each other. The device disclosed by the embodiment corresponds to the method disclosed by the embodiment, so that the description is simple, and the relevant points can be referred to the method part for description.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.

Claims (3)

1. The traditional Chinese medicine formula for treating bone diseases is characterized by comprising the following raw material medicines in parts by weight:
Figure FDA0002459707950000011
2. the traditional Chinese medicine formula for treating bone diseases according to claim 1, which is characterized in that the raw material medicines of the formula comprise, in parts by weight:
Figure FDA0002459707950000012
3. the traditional Chinese medicine formula for treating bone diseases according to claim 1, which is characterized in that the raw material medicines of the formula comprise, in parts by weight:
Figure FDA0002459707950000021
CN202010316280.2A 2020-04-21 2020-04-21 Traditional Chinese medicine formula for treating bone diseases Pending CN111407805A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010316280.2A CN111407805A (en) 2020-04-21 2020-04-21 Traditional Chinese medicine formula for treating bone diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010316280.2A CN111407805A (en) 2020-04-21 2020-04-21 Traditional Chinese medicine formula for treating bone diseases

Publications (1)

Publication Number Publication Date
CN111407805A true CN111407805A (en) 2020-07-14

Family

ID=71485693

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010316280.2A Pending CN111407805A (en) 2020-04-21 2020-04-21 Traditional Chinese medicine formula for treating bone diseases

Country Status (1)

Country Link
CN (1) CN111407805A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113952384A (en) * 2021-12-02 2022-01-21 福建中医药大学 Rongjinqubi prescription and preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104055973A (en) * 2014-07-11 2014-09-24 张秀荣 Traditional Chinese medicine liniment for treating rheumatoid bone diseases and arthralgia

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104055973A (en) * 2014-07-11 2014-09-24 张秀荣 Traditional Chinese medicine liniment for treating rheumatoid bone diseases and arthralgia

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113952384A (en) * 2021-12-02 2022-01-21 福建中医药大学 Rongjinqubi prescription and preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN101912572B (en) Multi-effect external plaster
CN103463381B (en) Traditional Chinese medicine preparation for treating rheumatism bone pain and preparation method thereof
CN102626505B (en) Massaging paste based on Chinese medicinal herbs and preparation method thereof
CN104258278A (en) Gushangling (for bone injury) spray
CN111407805A (en) Traditional Chinese medicine formula for treating bone diseases
CN108310070B (en) A Chinese medicinal composition for treating pain caused by hyperosteogeny of lumbar vertebra and cervical vertebra, and its preparation method
CN102139032B (en) Traditional Chinese medicine for treating intervertebral disc protrusion, hyperosteogeny and rheumatoid disease
CN103735756A (en) Traditional Chinese medicinal prescription for treating low back and leg pain
CN106511905A (en) Traditional Chinese medicine preparation used for curing cervical spondylosis and preparation method thereof
CN114028507A (en) Preparation method of traditional Chinese medicine for treating lumbago
CN104758527A (en) Traditional Chinese medicine composition for treating pain in waists and legs
CN105381393A (en) Traditional Chinese medicine ointment for treating scapulohumeral periarthritis
CN104398805A (en) Traditional Chinese medicine preparation for treatment of lumbar muscle strain and preparation method thereof
CN103961555A (en) Traditional Chinese medicine preparation for treating peripheral nerve injury and preparation method thereof
CN104027764A (en) Medicine for treating rheumatoid bone diseases
CN104338052A (en) Formula of traditional Chinese medicine for treating cerebral thrombosis
CN103893606B (en) Traditional Chinese medicine composition for treating scapulohumeral periarthritis
CN106563109B (en) Medicine for treating knee osteoarthritis and preparation method thereof
CN105943643A (en) Aiwei pain relieving powder and preparation process thereof
CN116196359A (en) Traditional Chinese medicine wine for treating rheumatism and traumatic injury and preparation method thereof
CN105012622A (en) Beverage for treating insomnia
CN105125978A (en) Traditional Chinese medicine preparation for treating rheumatic arthritis and preparation method thereof
CN112891409A (en) Traditional Chinese medicine composition for dispelling cold, expelling wind, removing arthralgia and relieving pain, application thereof and external preparation
CN102688391B (en) Traditional Chinese medicine (TCM) liquor for treating osteoporosis
CN104758675A (en) Traditional Chinese medicine composition for treating migraine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200714